Pacira (PCRX) Rips Over 22% Following Q3 Results, EXPAREL FDA Approval
Go back to Pacira (PCRX) Rips Over 22% Following Q3 Results, EXPAREL FDA Approval| PACIRA (NASDAQ: PCRX) | Delayed: 26.47 +0.57 (2.20%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $25.90 | 52 Week High | $80.25 | |||
| Open | $26.01 | 52 Week Low | $30.25 | |||
| Day High | $26.50 | P/E | N/A | |||
| Day Low | $25.98 | EPS | $-2.08 | |||
| Volume | 729,463 | |||||
